ABSTRACT
INTRODUCTION
Population studies have shown that the prevalence of maternal and fetal complications increases with advancing pregnancy beyond 39 weeks' gestation [1] [2] [3] . This pattern appears to be similar for both unselected populations and groups with risk factors, and there is evidence that elective birth from 39 weeks minimizes maternal and fetal risk 4 , except for specific groups like growth-restricted 5 and macrosomic 6 fetuses, morbidly obese women 7 , women older than 44 years 8 , women with cholestasis of pregnancy 9 and women with a multiple pregnancy 10 , who may benefit from even earlier scheduled delivery.
In this context, induction of labor at 39 weeks has been proposed as a means of ensuring optimal maternal and neonatal outcomes. The arguments against such a policy relate to theoretical concerns about logistics, cost and the consequences of failed induction 11 . However, there are both retrospective and prospective data showing that induction at 39 weeks may in fact decrease the rate of complications [12] [13] [14] [15] , including Cesarean section 15 , while no cost-effectiveness analysis of this policy is available to date. An additional factor, which is commonly overlooked, is women's preference and perception about induction of labor 16, 17 . As the largest randomized controlled trial (RCT) to date on this issue was published recently 15 , we performed a meta-analysis of randomized trials aiming to assess the impact of elective induction of labor at 39 weeks in uncomplicated singleton pregnancies on core maternal and fetal outcomes.
METHODS
This meta-analysis was structured and reported following a predefined protocol, according to the PRISMA guidelines, and is registered with PROSPERO (CRD42018106768).
Eligibility criteria
Only RCTs comparing elective induction of labor with expectant management in low-risk singleton pregnancy at term were considered eligible for inclusion. Studies reporting on high-risk pregnancies, multiple pregnancies, medically indicated inductions (e.g. for pre-eclampsia, growth restriction, macrosomia, preterm rupture of membranes), post-term pregnancy or trial of labor after Cesarean section were not considered eligible. Studies describing only women with a favorable or unfavorable Bishop score were also excluded, as recruitment of women based on their likelihood of successful induction would have led to selection bias.
Study participants were pregnant women with a singleton, low-risk pregnancy between 39 + 0 and 39 + 6 weeks' gestation. Interventions evaluated were induction of labor (any method, as defined by authors) between 39 + 0 and 39 + 6 weeks vs expectant management, i.e. anticipation of spontaneous onset of labor. Cases that underwent induction of labor for post-term (as defined in primary studies) pregnancy in the expectant arm were treated as expectant management cases.
Outcome measures
Primary outcomes included Cesarean section, admission of the neonate to the neonatal intensive care unit (NICU) and maternal death, defined as death of the woman during pregnancy and puerperium.
Secondary outcomes included: operative delivery (forceps or ventouse), significant (Grade-3/4) perineal laceration, postpartum hemorrhage (as defined in the primary studies), maternal infection (including postpartum endometritis), maternal hypertension, maternal thrombotic events, length of maternal hospital stay, neonatal death, need for neonatal respiratory support, neonatal cerebral palsy, length of neonatal stay in NICU, length of neonatal hospital stay and birth weight.
Information sources and search
PubMed, SCOPUS, the US Registry of Clinical Trials (www.clinicaltrials.com) and Cochrane CENTRAL were searched from inception to August 2018 for RCTs comparing induction of labor between 39 + 0 and 39 + 6 weeks with expectant management. Combinations of the terms 'induction', 'expectant' and 'randomize*' were used for the electronic searches (Table S1 ). Wide terms were used deliberately to avoid missing potentially eligible trials. In addition to database searches, the references of retrieved articles and of studies included in previous systematic reviews on the topic were perused. Only studies in European languages were considered.
Study selection and data extraction
Search results were screened by two of the authors (S.P., A.S.) and the full text of all relevant studies was reviewed. The same two authors independently assessed the eligibility of all the potential studies identified from the search. Data were extracted using a prespecified form. Any disagreement was resolved through discussion or, if required, through consultation with a third author (K.D.).
The variables for which data were sought (in addition to pregnancy outcomes and inclusion/exclusion criteria) included country in which the study was conducted, mean gestational age at randomization, mean maternal age, attrition rate and method of induction. In case of missing or unclear data, the authors of the primary studies were contacted for additional information.
Risk of bias of individual studies
The risk of bias in individual studies was assessed using the Cochrane Risk of Bias Tool 2.0 18 . This tool assesses potential bias in five domains: randomization process; deviation from intended intervention; missing outcome data; measurement of the outcome; and selection of the reported result. For each domain, the judgment of bias may indicate either high or low risk, or presence of some concerns. According to the instructions for the tool, an overall 'low risk of bias' was allocated for a given result when the risk of bias was low for all domains for this result; 'some concerns' when there were some concerns in at least one domain for this result; and 'high risk of bias' when there was high risk in at least one domain or some concerns for multiple domains in a way that substantially lowered confidence in the result 18 .
Quality of evidence
The overall quality of evidence for the primary and secondary outomes was assessed as per GRADE guideline 19, 20 , using the GRADEpro GD tool. Briefly, GRADE is a system for rating the quality of evidence in systematic reviews and guidelines using a scoring system across five fields, namely, risk of bias, inconsistency, indirectness, imprecision and publication bias. GRADE specifies four categories for the quality of a body of evidence. This reflects the degree of confidence of how close our estimate of the effect lies to the true effect. High quality level means that we are very confident that the true effect lies close to the estimate of the effect calculated by the meta-analysis. The level of confidence decreases with decreasing quality (high → moderate → low → very low), and very low quality means that the true effect is likely to be substantially different from that estimated in the review 20 .
Summary measures and synthesis of results
For dichotomous data, summary risk ratios (RRs) with 95% CIs were calculated. Mean difference was calculated for continuous outcomes, if they were measured in the same way between trials. Random-effects models (DerSimonian and Laird) were used for data synthesis. For each outcome, the number needed to treat (NNT) was also calculated based on pooled effect sizes. NNT is defined by the inverse of the absolute value of the risk difference, and it shows the number of patients who need to be treated using one intervention rather than its comparator in order to have one more event of interest (e.g. success).
Between-study heterogeneity was assessed using the I 2 statistic, which is the ratio of between-study variance over the sum of the within-and between-study variances, and describes the percentage of the true effect variation that is due to heterogeneity rather than chance (range, 0-100%). A simplistic grouping would assign descriptions of low, moderate and high heterogeneity to I 2 values of 25%, 50% and 75%, respectively 21 .
The unit of analysis was the mother for maternal outcomes and the fetus/neonate for perinatal outcomes. The initial number of cases was the same for maternal and fetal outcomes, as only singleton pregnancies with live fetuses at randomization were included.
Statistical analysis was carried out using Stata 14.0 software (StataCorp., College Station, TX, USA).
Subgroup and sensitivity analyses
We planned to perform a sensitivity analysis of studies at low risk of bias and a meta-regression for maternal age and method of induction.
Publication bias
We planned a priori to investigate reporting biases (such as publication bias) using funnel plots, if there were 10 or more studies in the meta-analysis. We planned to assess funnel plot asymmetry visually, and perform exploratory analyses using formal statistical tests if asymmetry was suggested. However, only five studies were included in this review, and thus, the evaluation of publication bias was suboptimal.
RESULTS

Study selection
The electronic search and complementary hand-searching of references yielded 811 titles. After removal of duplicates (n = 62) and exclusion of studies based on title/abstract, we assessed 32 studies in full text (Figure 1 ). Twenty-seven of them were excluded with reasons (Table S2) . Two of these studies would be otherwise eligible, but were excluded because their participants were exclusively women with favorable 22 or unfavorable 23 Bishop scores, which made them susceptible to selection bias. Eventually, five studies 14, 15, [24] [25] [26] were included in the analysis, which involved 7261 cases, 3629 allocated to elective induction and 3632 to expectant management. A single study 15 represented 84% of all participants.
Study characteristics
Characteristics of the included studies are shown in Table 1 . The largest study was performed in the USA 15 , three in the UK 14, 24, 26 and one in Japan 25 . Three studies included only nulliparous women and two 24, 26 included both nulliparous and parous women with a favorable obstetric history. The methods of labor induction varied both across and within studies, involving amniotomy, laminarias, oxytocin and prostaglandins. Table 2 . None of the studies was judged as having an overall low risk of bias. All studies had unavoidably open-label design, which might have affected the rate of successful induction and thereby a string of outcomes, starting with the mode of delivery. There were some concerns for bias in two of the studies 14, 15 , and the other three [24] [25] [26] were judged as being at high risk of bias. A common limitation of the latter three studies [24] [25] [26] was that they provided insufficient information about the randomization methods, allocation concealment and handling of the results.
Risks of bias within studies
Assessment of risk of bias according to the Cochrane Risk of Bias Tool v.2 is shown in
Results of individual studies
The results of the individual studies are presented in Table S3 . All five studies reported on the rate of Cesarean section, three studies 14, 15, 25 presented information about NICU admission and one 15 about maternal death. There was no information about thrombotic maternal complications, length of hospital stay, cerebral palsy, length of NICU stay and hospital stay for the neonate.
Synthesis of results
All included studies 14, 15, [24] [25] [26] reported on Cesarean section (7261 participants; 1471 women underwent Cesarean section). Elective induction of labor was associated with a reduced risk for Cesarean section (RR 0.86 (95% CI, 0.78-0.94); I 2 = 0.1%) ( Figure 2 , Table 3 ). The number of elective inductions needed to prevent one Cesarean section was 32.
Only one study 15 examined maternal death, and no death occurred among the 6096 participants.
Three studies 14, 15, 25 reported on NICU admission (6849 cases; 767 admissions to NICU). There was no significant difference between induction of labor and expectant management with respect to risk of NICU admission (RR 0.90 (95% CI, 0.79-1.03); I 2 = 0%) ( Figure 3 , Table 3 ).
Regarding secondary outcomes, there was no difference between the two groups in the rates of operative delivery (five studies 14, 15, [24] [25] [26] , 7261 participants; 854 operative deliveries; RR 1.11 (95% CI, 0.88-1.41); I 2 = 65.5%), Grade-3/4 perineal laceration (two studies 14, 15 , 6714 women, 199 with Grade-3/4 perineal laceration; RR 1.18 (95% CI, 0.89-1.50); I 2 = 0%), postpartum hemorrhage (two studies 14, 15 , 6714 women, 464 with postpartum hemorrhage; RR 1.06 (95% CI, 0.90-1.25); I 2 = 0%) and postpartum maternal infection (two studies 14, 15 , 6714 women, 137 with postpartum infection; RR 0.84 (95% CI, 0.58-1.22); I 2 = 9.8%) ( Table 3) . Two studies 14, 15 reported on hypertensive disease of pregnancy (6714 women, 741 with hypertensive disease of pregnancy). Elective induction at 39 weeks was associated with a significant decrease in the risk of hypertension (RR 0.65 (95% CI, 0.57-0.75); I 2 = 0%, NNT = 21) ( Figure S1 ).
Regarding neonatal outcomes, there was no difference between the two groups in the risk of neonatal death (four studies 14, 15, 24, 26 , 7126 neonates; six cases of neonatal death; RR 0.57 (95% CI, 0.12-2.71); I 2 = 0%). Induction of labor was associated with a significant reduction in the need for neonatal respiratory support (two studies 14, 15 , 6714 neonates; 250 needed support; RR 0.73 (95% CI, 0.58-0.95); I 2 = 0%) ( Figure S2 ). Neonates born after induction of labor had significantly lower mean birth weight than those in the expectant management group (three studies 14, 15, 26 , 6942 neonates; pooled mean difference -81 g (95% CI, -100 to -63 g);
There were insufficient published data to perform the prespecified subgroup and sensitivity analyses.
Overall quality of evidence
The overall quality of the evidence (Table 3) was moderate for Cesarean section, maternal hypertension and need for neonatal respiratory support; low for NICU admission, Grade-3/4 perineal laceration, postpartum hemorrhage and postpartum maternal infection; and very low for operative vaginal delivery and neonatal death. All outcomes were downgraded by one level for bias, as all evidence was derived exclusively from studies at high risk, or with some concerns, of bias. Several outcomes were further downgraded by one level for imprecision, as the 95% CIs of their pooled effect sizes included the unit; neonatal death was downgraded by two levels, as the number of events (n = 6) was too small to reach any robust conclusion. Operative delivery was also downgraded by one level because of inconsistency, as the corresponding studies indicated heterogeneous direction of effect. 25 Grobman (2018) 15 Walker (2016) 
DISCUSSION
Summary of evidence
Our synthesis of evidence from RCTs showed that, compared with expectant management, elective induction of labor at 39 weeks' gestation in uncomplicated singleton pregnancies is associated with a reduced risk of Cesarean section (RR 0.86, moderate quality of evidence), reduced risk of maternal hypertension (RR 0.65, moderate quality of evidence) and reduced need for neonatal respiratory support (RR 0.73, moderate quality of evidence). There is no indication that elective induction of labor from 39 weeks is associated with an adverse effect on maternal or neonatal outcomes.
Interpretation of results
The rationale supporting elective induction of labor at 39 weeks is that population data demonstrate an increase in the rate of perinatal and maternal complications in both unselected and complicated pregnancies after 38-39 weeks 1-3 . The major counterarguments against such a policy have been the concerns for failed induction and the concomitant risk for maternal and neonatal complications, mostly arising from retrospective studies 27, 28 . Our results do not support these concerns. Elective induction at 39 weeks may, in fact, result in a relative reduction in the rate of Cesarean section, from approximately 22% with expectant management to approximately 19% with induction (NNT = 32). This does not appear to happen at the expense of an increase in the rate of operative deliveries. A possible explanation is that 39 weeks is the optimal time for induction. Women who continue their pregnancy beyond 39 weeks become progressively less likely to have a successful induction 29 . This may reflect increasing rates of failure to progress in labor (as the fetus becomes larger there is a higher risk of cephalopelvic disproportion) and increasing risks of fetal distress due to a simultaneous decrease in placental reserve 30 . In our analysis, the mean birth weight of neonates in the induction group was approximately 80 g lower than that of those in the expectant management group, although it is not clear if this difference affected the chance of successful induction.
We found that induction of labor at 39 weeks can decrease the risk of hypertensive disease of †GRADE Working Group grades of evidence: high certainty, we are very confident that true effect lies close to that of estimate of effect; moderate certainty, we are moderately confident in effect estimate -true effect is likely to be close to estimate of effect, but there is a possibility that it is substantially different; low certainty, our confidence in effect estimate is limited -true effect may be substantially different from estimate of effect; very low certainty, we have very little confidence in effect estimate -true effect is likely to be substantially different from estimate of effect. ‡Data are derived exclusively from studies at concern for bias or at high risk of bias. §95% CI for pooled effect sizes includes the unit. ¶Different direction of effect across studies. #Very small number of events. NICU, neonatal intensive care unit; NNT, number needed to treat (calculated only when significant difference was observed).
pregnancy, from approximately 13% with expectant management to approximately 9% (NNT = 21). We hypothesize that the beneficial effect of induction at 39 weeks is mediated mainly through the prevention of hypertensive complications that would manifest later, should pregnancy continue 31, 32 .
A third potentially beneficial effect of induction was the reduced need for respiratory support of the neonate, from approximately 4% with expectant management to approximately 3% when performing induction of labor at 39 weeks (NNT = 83). A retrospective study of 5000 non-anomalous term fetuses found that the presence of meconium increases the risk for respiratory distress by 3.3 times and Cesarean section by 4.2 times 33 , and it is likely that the improvement in respiratory outcomes is related to a reduction in meconium exposure before birth (RR 0.23 (95% CI, 0.06-0.98) for the studies included in this meta-analysis; not a prespecified outcome).
Strengths and limitations
Our strict selection methodology ensured that our results describe a well-defined population of singleton uncomplicated pregnancies between 39 + 0 and 39 + 6 weeks' gestation. In this context, we excluded two otherwise eligible studies, one of them including only women with favorable 22 and one including only women with unfavorable 23 cervix score, as both of them would be at theoretical risk of selection bias. Our focus on singleton uncomplicated pregnancies at 39 weeks differentiates our meta-analysis from previous systematic reviews [34] [35] [36] [37] , which analyzed term pregnancies (i.e. ≥ 37 weeks' gestation) as a group [34] [35] [36] [37] , included all indications for induction in their main analyses [34] [35] [36] [37] or assessed only the impact of induction on the rate of Cesarean section 34 . Moreover, none of the previous meta-analyses included data from the ARRIVE trial 15 , which contributed more than 80% of the total sample of our target population.
The main limitation of our analysis was that most of the data were derived from a single large study 15 , which, depending on the outcome, contributed from 29% to 97% of the data. A second limitation arose from the unavoidably open-label/unblinded design of all included studies, which might affect the preparedness of the attending clinician to resort to Cesarean section. Although this is mostly a theoretical concern, and it is not possible to safely predict its direction of effect, we downgraded all outcomes by one degree of bias. There were no data for many of our predefined outcomes, and insufficient data to perform subgroup and sensitivity analyses. The methods of induction differed across and within studies, preventing us from exploring the potential impact of different methods on the observed results; previous pooled results indicate that cervical ripening before induction of contractions increases the likelihood of success 34 . Moreover, there was no information amenable to quantitative synthesis from the included studies to gauge the impact of systematic induction on women's satisfaction and experience, although data from the largest included study indicate similar scores of perceived control during childbirth in the two groups 15 . Finally, the small number of included studies did not allow a formal evaluation of publication bias; however, this is likely to be low, judging from the dispersion of the estimates even in smaller studies.
Generalizability and applicability
Almost all the data in our study were derived from studies of nulliparous women having an uncomplicated singleton pregnancy between 39 + 0 and 39 + 6 weeks. Therefore, our results are applicable only to such women, and their generalization to the entire population is uncertain.
Although the Society for Maternal and Fetal Medicine issued a response to the ARRIVE study 15 proposing that it is reasonable to offer elective induction of labor to low-risk nulliparous women at or beyond 39 weeks 38 , there are still significant unresolved issues. Thus, there are no data on how such a policy would affect the logistics and cost of maternity care. Also, the included studies do not provide information on the long-term neurodevelopmental impact of induction at 39 weeks. This is an important consideration, given the retrospective observational data showing that the nadir of special educational need is reached for children born at 40-41 weeks 39, 40 . In this context, the most likely subgroup to benefit from an induction policy might be nulliparous women with risk factors for hypertensive or other medical or fetal complications of pregnancy.
Conclusions
There is moderate-quality evidence that elective induction of labor in uncomplicated singleton pregnancy at 39 weeks' gestation may be associated with reduced risk of Cesarean section, maternal hypertension and need for respiratory support in the neonate. Unresolved issues, should systematic induction be adopted, involve logistics, cost, the preferences of women and possibly the long-term neurodevelopmental outcome of the offspring.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article: Resultados maternos y perinatales después de la inducción electiva del parto a las 39 semanas en embarazos con fetoúnico sin complicaciones: un metaanálisis RESUMEN Objetivo La tasa de complicaciones maternas y perinatales aumenta después de las 39 semanas de gestación, tanto en los embarazos no seleccionados como en los complicados. El objetivo de este estudio fue sintetizar cuantitativamente la evidencia disponible sobre el efecto de la inducción electiva del parto a las 39 semanas sobre el riesgo de cesárea y sobre los resultados maternos y perinatales.
Métodos Se realizaron búsquedas en las bases de datos PubMed, Registro Estadounidense de Ensayos Clínicos, SCOPUS y CENTRAL, desde su inicio hasta agosto de 2018. Además, se realizaron búsquedas en las referencias de los artículos recuperados. Los estudios elegibles fueron ensayos controlados aleatorizados de embarazos con fetó unico sin complicaciones en los que las participantes fueron asignadas al azar entre las 39+0 y 39+6 semanas de gestación a la inducción del parto o al tratamiento expectante. El riesgo de sesgo de los estudios individuales se evaluó mediante la Herramienta Cochrane de Riesgo de Sesgo. La calidad general de la evidencia se evaluó de acuerdo con las directrices de GRADE. Los resultados principales incluyeron cesárea, muerte materna e ingreso a la unidad de cuidados intensivos neonatales (UCIN). Los resultados secundarios incluyeron parto quirúrgico, laceración perineal de grado 3/4, hemorragia puerperal, infección materna, enfermedades hipertensivas del embarazo, episodios trombóticos maternos, duración de la estancia materna en el hospital, muerte neonatal, necesidad de ayuda respiratoria al neonato, parálisis cerebral, duración de la estancia en la UCIN y duración de la estancia en el hospital del neonato. Se calcularon los cocientes de riesgo (CR) combinados mediante un modelo de efectos aleatorios.
Resultados El metaanálisis incluyó cinco estudios (7261 casos). La inducción del parto se asoció con una disminución del riesgo de cesárea (calidad moderada de la evidencia; CR 0,86 (IC 95%: 0,78-0,94); I 2 = 0,1%), hipertensión materna (calidad moderada de las pruebas; CR 0,65 (IC 95%: 0,57-0,75); I 2 = 0%) y apoyo respiratorio neonatal (calidad moderada de las pruebas; CR 0,73 (IC 95%: 0,58-0,95); I 2 = 0%). Los neonatos nacidos después de la inducción pesaron, en promedio, 81 g (IC 95%: 63-100 g) menos que los nacidos después del tratamiento expectante. No se encontraron efectos significativos para los otros resultados con los datos disponibles. El limitante principal de nuestro análisis fue que la mayoría de los datos se derivaron de unúnico gran estudio. Una segunda limitación surgió del diseño abierto de los estudios, que teóricamente podría haber afectado a la predisposición del médico tratante para recurrir a la cesárea.
Conclusiones La inducción electiva del parto en embarazos no complicados con fetoúnico a las 39 semanas de gestación no está asociada con complicaciones maternas o perinatales y puede reducir la necesidad de una cesárea, el riesgo de enfermedades hipertensivas del embarazo y la necesidad de ayuda respiratoria para el neonato.
